Use of new diet drugs likely to mushroom

Updated on: November 30,2024 0

Use of new diet drugs likely to mushroom

Updated on:November 30,2024 0

Without immediate action, nearly 260 million people in the US predicted to be overweight or obese by 2050

byLancetCredit: Unsplash/CC0 Public DomainOver the past three decades, there has been a startling increase in the prevalence of obesity across the U.S., at least doubling in adult men and women

Updated on: December 05,2024 0

Without immediate action, nearly 260 million people in the US predicted to be overweight or obese by 2050

byLancetCredit: Unsplash/CC0 Public DomainOver the past three decades, there has been a startling increase in the prevalence of obesity across the U.S., at least doubling in adult men and women

Updated on:December 05,2024 0

Researchers Develop Wearable Ultrasound Patch for Continuous Blood Pressure Monitoring

A team at the University of California San Diego has created an advanced wearable ultrasound patch designed for continuous, non-invasive blood pressure monitoring.

Updated on: December 07,2024 0

Researchers Develop Wearable Ultrasound Patch for Continuous Blood Pressure Monitoring

A team at the University of California San Diego has created an advanced wearable ultrasound patch designed for continuous, non-invasive blood pressure monitoring.

Updated on:December 07,2024 0

Eating dark chocolate linked to reduced risk of type 2 diabetes: Clinical trials needed to confirm, say experts

byBritish Medical JournalCredit: CC0 Public DomainEating five servings of dark chocolate a week is associated with a reduction in the risk of type 2 diabetes, according to a long-term US study&n

Updated on: December 11,2024 0

Eating dark chocolate linked to reduced risk of type 2 diabetes: Clinical trials needed to confirm, say experts

byBritish Medical JournalCredit: CC0 Public DomainEating five servings of dark chocolate a week is associated with a reduction in the risk of type 2 diabetes, according to a long-term US study&n

Updated on:December 11,2024 0

Researchers in Japan discover new antidiabetic compound

byKumamoto UniversityHPH-15 offers multiple benefits for managing type 2 diabetes, including effective blood glucose control, reduced risk of lactic acidosis, improved insulin resistance, and su

Updated on: December 11,2024 0

Researchers in Japan discover new antidiabetic compound

byKumamoto UniversityHPH-15 offers multiple benefits for managing type 2 diabetes, including effective blood glucose control, reduced risk of lactic acidosis, improved insulin resistance, and su

Updated on:December 11,2024 0

Handgrip strength could be predictor of diabetes risk in postmenopausal women

byThe North American Menopause SocietyCredit: Blue Bird from PexelsAs the average age of the population increases, so does the incidence of diabetes, which is the most expensive chronic disease

Updated on: December 11,2024 0

Handgrip strength could be predictor of diabetes risk in postmenopausal women

byThe North American Menopause SocietyCredit: Blue Bird from PexelsAs the average age of the population increases, so does the incidence of diabetes, which is the most expensive chronic disease

Updated on:December 11,2024 0

An affordable and effective nutritional approach to help reduce inflammation and prevent type 2 diabetes

byUniversity of MontrealCredit: CC0 Public DomainA team sheds new light on the role of marine-source omega-3 supplementation in treating adipose tissue inflammation and reducing the risk for car

Updated on: December 11,2024 0

An affordable and effective nutritional approach to help reduce inflammation and prevent type 2 diabetes

byUniversity of MontrealCredit: CC0 Public DomainA team sheds new light on the role of marine-source omega-3 supplementation in treating adipose tissue inflammation and reducing the risk for car

Updated on:December 11,2024 0

Zepbound bests Wegovy for weight loss in new trial

by Robin FosterZepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly."Given the increased interest a

Updated on: December 18,2024 0

Zepbound bests Wegovy for weight loss in new trial

by Robin FosterZepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly."Given the increased interest a

Updated on:December 18,2024 0

Taking high-dose vitamin D supplements for five years shown not to affect incidence of type 2 diabetes

byUniversity of Eastern FinlandCumulative incidence of type 2 diabetes in the three study arms during the 5 year supplementation period. Credit:Diabetologia(2024). DOI: 10.1007/s0012

Updated on: December 18,2024 0

Taking high-dose vitamin D supplements for five years shown not to affect incidence of type 2 diabetes

byUniversity of Eastern FinlandCumulative incidence of type 2 diabetes in the three study arms during the 5 year supplementation period. Credit:Diabetologia(2024). DOI: 10.1007/s0012

Updated on:December 18,2024 0

Obesity treatment in a natural, food-grade microcapsule has no unpleasant side effects

byUniversity of South AustraliaA graphical schematic depicting the spray drying process of an aqueous dispersion of inulin and an MCT emulsion. Spray-dried InuMCT reaches the GIT, where inulin i

Updated on: December 18,2024 0

Obesity treatment in a natural, food-grade microcapsule has no unpleasant side effects

byUniversity of South AustraliaA graphical schematic depicting the spray drying process of an aqueous dispersion of inulin and an MCT emulsion. Spray-dried InuMCT reaches the GIT, where inulin i

Updated on:December 18,2024 0

About one-third eligible for weight loss drugs meet trial exclusion criteria

by Elana GotkineAbout one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 (GLP-1) receptor agonists and GLP-1/glucose-dependent insulinotr

Updated on: December 18,2024 0

About one-third eligible for weight loss drugs meet trial exclusion criteria

by Elana GotkineAbout one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 (GLP-1) receptor agonists and GLP-1/glucose-dependent insulinotr

Updated on:December 18,2024 0

Nature reveals: Fat cells have a “memory”

Updated on: December 20,2024 0

Nature reveals: Fat cells have a “memory”

Updated on:December 20,2024 0